Geneva, July 7 -- International Clinical Trials Registry received information related to the study (ChiCTR2600127110) titled 'A cohort study establishing a high-risk warning model for progressive hepatic fibrosis in metabolic-associated fatty liver disease (MASLD) among patients with type 2 diabetes and overweight or obesity' on June 24.
Study Type: Observational study
Study Design:
Sequential
Primary Sponsor: the Second Affiliated Hospital of Army Medical University (Xinqiao Hospital)
Condition:
metabolic associated fatty liver disease
Recruitment Status: Not Recruiting
Phase: Retrospective study
Date of First Enrollment: 2026-06-30
Target Sample Size: Case series:1200;
Countries of Recruitment:
China
To know more, visit ...